Novo Nordisk Pharmaceutical Industries, LP
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3612 Powhatan Road, Clayton, North Carolina (NC) 27527, United States (USA)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 1000158576 · DUNS 622920320
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-06-13
- NAIDrug Quality Assurance2018-01-12
- NAIDrug Quality Assurance2014-08-21
- NAIDrug Quality Assurance2012-08-16
- NAIDrug Quality Assurance2011-07-01
- NAIDrug Quality Assurance2010-09-03
- VAIDrug Quality Assurance2009-09-02
Drugs this plant is listed as making
2 distinct drugs across 5 products name this site in their FDA label.
- liraglutidein shortageNovo Nordisk
- semaglutideNovo Nordisk Pharmaceutical Industries, LP
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.